C World Wide Group Holding A Eli Lilly & CO Transaction History

C World Wide Group Holding A

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 02, 2019	SELL	$110.79 - $129.32 $10.2 Million - $11.9 Million	-91,848 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$75.7 - $86.88 $2.52 Million - $2.89 Million	-33,272 Reduced 26.59%	91,848 $7.84 Million
Q3 2017 Nov 06, 2017	BUY	$77.07 - $85.54 $9.64 Million - $10.7 Million	125,120	125,120 $10.7 Million

4,016

739M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.